Enzo Biochem, Inc. (ENZ)

USD 0.71

(0.73%)

Total Debt Summary of Enzo Biochem, Inc.

  • Enzo Biochem, Inc.'s latest annual total debt in 2024 was 265 Thousand USD , down -49.86% from previous year.
  • Enzo Biochem, Inc.'s latest quarterly total debt in 2024 Q3 was 7.25 Million USD , up 1.07% from previous quarter.
  • Enzo Biochem, Inc. reported annual total debt of 6.99 Million USD in 2023, down -66.01% from previous year.
  • Enzo Biochem, Inc. reported annual total debt of 20.58 Million USD in 2022, down -9.21% from previous year.
  • Enzo Biochem, Inc. reported quarterly total debt of 7.02 Million USD for 2024 Q1, up 0.43% from previous quarter.
  • Enzo Biochem, Inc. reported quarterly total debt of 265 Thousand USD for 2024 Q4, down -51.65% from previous quarter.

Annual Total Debt Chart of Enzo Biochem, Inc. (2024 - 1989)

Historical Annual Total Debt of Enzo Biochem, Inc. (2024 - 1989)

Year Total Debt Total Debt Growth
2024 265 Thousand USD -49.86%
2023 6.99 Million USD -66.01%
2022 20.58 Million USD -9.21%
2021 22.67 Million USD -30.84%
2020 32.79 Million USD 612.36%
2019 4.6 Million USD 1203.97%
2018 353 Thousand USD -38.39%
2017 573 Thousand USD -76.67%
2016 2.45 Million USD -31.51%
2015 3.58 Million USD -12.88%
2014 4.11 Million USD -5.79%
2013 4.36 Million USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD -100.0%
2005 200 Thousand USD -33.33%
2004 300 Thousand USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%
2001 - USD 0.0%
2000 - USD 0.0%
1999 - USD 0.0%
1998 - USD -100.0%
1997 100 Thousand USD -50.0%
1996 200 Thousand USD -95.83%
1995 4.8 Million USD -26.15%
1994 6.5 Million USD 6.56%
1993 6.1 Million USD 0.0%
1992 6.1 Million USD -83.38%
1991 36.7 Million USD -20.22%
1990 46 Million USD -6.88%
1989 49.4 Million USD 2.28%

Peer Total Debt Comparison of Enzo Biochem, Inc.

Name Total Debt Total Debt Difference
Agilent Technologies, Inc. 2.73 Billion USD 99.99%
Charles River Laboratories International, Inc. 3.06 Billion USD 99.991%
Quest Diagnostics Incorporated 5.36 Billion USD 99.995%
Danaher Corporation 19.53 Billion USD 99.999%
IQVIA Holdings Inc. 14.23 Billion USD 99.998%
Laboratory Corporation of America Holdings 5.95 Billion USD 99.996%
Mettler-Toledo International Inc. 2.08 Billion USD 99.987%
Qiagen N.V. 1.61 Billion USD 99.984%
Revvity, Inc. 4.03 Billion USD 99.993%
Thermo Fisher Scientific Inc. 34.91 Billion USD 99.999%
Waters Corporation 2.35 Billion USD 99.989%